Summit Therapeutics SMMT Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Summit Therapeutics's compensation and benefits?
- Summit Therapeutics (SMMT) reported compensation and benefits of $7.07M in Q1 2026.
- How has Summit Therapeutics's compensation and benefits changed year-over-year?
- Summit Therapeutics's compensation and benefits increased by 60.9% year-over-year, from $4.4M to $7.07M.
- What is the long-term trend for Summit Therapeutics's compensation and benefits?
- Over 5 years (2020 to 2025), Summit Therapeutics's compensation and benefits has grown at a 72.3% compound annual growth rate (CAGR), from $983K to $14.93M.